Some patents
| WO 2012070963 A1 US 20130288230 A1 |
Method for identification of a natural biopolymer | |
| US 20120195911 A1 |
Method of treatment of cancer patients |
|
| WO2012070965 |
Modified anticomplementary oligonucleotides with anticancer properties and method for producing same |
|
| WO2012070964 | Modified oligopeptides with anticancer properties and method for producing same | |
| WO2012070973 |
Method for treating cancer patients |
|
| WO2012070972 US 20120195856 A1 |
Method of treating patients with cardiovascular illness | |
| WO2012070970 US 20120129153 A1 |
Diagnostic method for the prediction of the development and control of the effectiveness of the treatment of oncological illnesses |
|
| WO2012070974 US 20120195925 A1 |
Vaccines with enhanced immunogenicity and methods for the production thereof | |
| WO2013100792 | Method for accelerating bacterial biomass growth and attenuating the virulence of bacteria | |
| WO2012070971 US 8846064 B2 |
Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly | |
| US 20120129787 A1 | Modified oligopeptides with anticancer properties and methods of obtaining them | |
| WO2012070968 EP 2644617 A1 US 20140220556 A1 |
Method for the molecular design and synthesis of therapeutic and preventive drugs | |
| US 20120196801 A1 | Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration | |
| US 20120130060 A1 | Modified antisense oligopeptides with anticancer properties and method of obtaining them | |
| WO 2012070975 A1 US 20120129760 A1 |
Modified peptides with antiviral properties and methods for obtaining them | |
| WO2012070969 | Diagnostic method for predicting the development of cardiovascular diseases and monitoring treatment efficacy | |
| US 20120129195 A1 | Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation |
|
| WO2012070967 | Wound-healing, burn-treating, regenerative and antiviral pharmaceutical composition for topical application | |
| US 20120129152 A1 | Diagnostic method for the prediction of the development of and control over the effectiveness of treatment of cardiovascular illnesses |
|
| US 20120197003 A1 | Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them |